Table 1 Baseline characteristics of subjects who were randomized to receive treatment with either EE/CMA or EE/DRSP

From: A comparison of combined oral contraceptives containing chlormadinone acetate versus drospirenone for the treatment of acne and dysmenorrhea: a randomized trial

  EE/CMAa
(n = 90)
EE/DRSPa
(n = 90)
Age (yrs) 28.5 ± 6.99 27.2 ± 6.05
Height (cm) 158.4 ± 5.79 158.2 ± 4.92
Weight (kg) 56.5 ± 10.02 56.1 ± 8.19
BMI (kg/m2) 22.5 ± 3.36 22.4 ± 3.25
Systolic BP (mmhg) 112.1 ± 11.49 110.3 ± 11.39
Diastolic BP (mmhg) 67.2 ± 9.76 67.0 ± 9.35
  1. aContinuous variables are presented as mean ± S.D